Jennifer Dove
Primary Care · Whiteville, NCNPI 1780138479
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,201 and has fallen 91.2% since, to $194 in 2025. Among primary care clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 216 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$605
- AstraZeneca$453
- Novo Nordisk$401
- Abbott$336
- Sanofi-aventis U.S. LLC$240
- Lilly USA, LLC$220
- plus $2K from 23 others
What the payments were for
- Food & beverage$3,955100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 13 | $605 |
| AstraZeneca | 22 | $453 |
| Novo Nordisk | 40 | $401 |
| Abbott | 20 | $336 |
| Sanofi-aventis U.S. LLC | 14 | $240 |
| Lilly USA, LLC | 15 | $220 |
| Boehringer Ingelheim | 12 | $214 |
| Amgen(2 entities) | 13 | $187 |
| Galderma Laboratories, L.p. | 8 | $168 |
| Antares Pharma, Inc. | 10 | $161 |
| Insulet Corporation | 4 | $129 |
| Corcept Therapeutics | 6 | $128 |
| Esperion Therapeutics, Inc. | 6 | $113 |
| Dexcom, Inc. | 1 | $103 |
| Merck | 6 | $81 |
| Bayer | 4 | $73 |
| Amarin Pharma, Inc. | 4 | $53 |
| IBSA Pharma Inc. | 3 | $49 |
| Xeris Pharmaceuticals, Inc. | 3 | $39 |
| Tandem Diabetes Care, Inc. | 2 | $35 |
| Merz North America, Inc. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| GRT US Holding, Inc. | 1 | $21 |
| Pfizer | 1 | $16 |
| Radius Health, Inc. | 1 | $15 |
| Boston Scientific | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Medtronic | 1 | $13 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$144
- FARXIGA$125
- DEXCOM G6 TRANSMITTER$103
How this compares
$3,955 in reported general payments places this provider in the 90th percentile of 236 primary care providers in North Carolina.
Other primary care in Whiteville
- Jessica AllynRaleigh$21K
- Jennifer RogersWinston Salem$17K
- Elizabeth WaltersChapel Hill$14K
- Ragan JohnsonChapel Hill$13K
- Kirkland DickeyPine Hall$11K
- Kimberly WeaverHickory$9K
- Amanda StoneWilmington$9K
- Elizabeth WalshGreensboro$7K
- Mark HollingsworthWilmington$7K
- Crystal GoinsFayetteville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.